The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Sommer, Morten Otto Alexander
    Director born in November 1981
    Individual (2 offsprings)
    Officer
    2018-03-22 ~ now
    OF - Director → CIF 0
  • 2
    Skinner, Henry Bradford
    Venture Capitalist born in March 1964
    Individual (2 offsprings)
    Officer
    2023-10-20 ~ now
    OF - Director → CIF 0
  • 3
    Hadley, Thomas
    Acting President And Ceo born in August 1965
    Individual (1 offspring)
    Officer
    2023-10-20 ~ now
    OF - Director → CIF 0
  • 4
    Roemer, Alan Sloane
    Director born in February 1970
    Individual (1 offspring)
    Officer
    2020-03-31 ~ now
    OF - Director → CIF 0
  • 5
    Davis, Andrew R
    Manager born in August 1985
    Individual (1 offspring)
    Officer
    2019-08-16 ~ now
    OF - Director → CIF 0
  • 6
    Edwards, Larry Grante
    President And Ceo La Jolla Pharmaceutical Co. born in May 1971
    Individual (1 offspring)
    Officer
    2021-02-24 ~ now
    OF - Director → CIF 0
  • 7
    Toft-kehler, Rasmus Vendler
    Director born in August 1980
    Individual (2 offsprings)
    Officer
    2018-03-22 ~ now
    OF - Director → CIF 0
Ceased 7
  • 1
    Granata, Francesco, Dr
    Director born in October 1950
    Individual (1 offspring)
    Officer
    2018-09-24 ~ 2020-03-31
    OF - Director → CIF 0
  • 2
    Skov, Ole
    Director born in March 1960
    Individual (2 offsprings)
    Officer
    2018-03-22 ~ 2020-01-21
    OF - Director → CIF 0
  • 3
    Mr Rasmus Vendler Toft-kehler
    Born in August 1980
    Individual (2 offsprings)
    Person with significant control
    2017-12-19 ~ 2017-12-22
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 4
    Beards, Mark Granville
    Manager born in March 1970
    Individual (3 offsprings)
    Officer
    2017-12-19 ~ 2020-03-31
    OF - Director → CIF 0
  • 5
    C/o Morten Sommer, Duntzfelts Alle 22, Hellerup, Denmark
    Corporate
    Person with significant control
    2017-12-22 ~ 2017-12-22
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 6
    Ensign House, Unit A, Battersea Reach, Juniper Drive, London, United Kingdom
    Dissolved Corporate (2 parents, 430 offsprings)
    Equity (Company account)
    100 GBP2022-09-30
    Officer
    2017-12-19 ~ 2020-06-03
    PE - Secretary → CIF 0
  • 7
    C/o Rasmus Toft-kehler, Wilhelm Marstrands Gade 22, Copenhagen ø, Denmark
    Corporate
    Person with significant control
    2017-12-22 ~ 2017-12-22
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

UTILITY THERAPEUTICS LTD

Previous name
UTILITY THERAPEUTICS GROUP LTD - 2018-02-06
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Par Value of Share
Class 1 ordinary share
02023-01-01 ~ 2023-12-31
Debtors
212,625 GBP2023-12-31
521,857 GBP2022-12-31
Cash at bank and in hand
3,889,160 GBP2023-12-31
121,429 GBP2022-12-31
Current Assets
4,101,785 GBP2023-12-31
643,286 GBP2022-12-31
Creditors
Current
2,550 GBP2023-12-31
2,400 GBP2022-12-31
Net Current Assets/Liabilities
4,099,235 GBP2023-12-31
640,886 GBP2022-12-31
Total Assets Less Current Liabilities
4,099,235 GBP2023-12-31
640,886 GBP2022-12-31
Creditors
Non-current
5,203,306 GBP2023-12-31
368,517 GBP2022-12-31
Net Assets/Liabilities
-1,104,071 GBP2023-12-31
272,369 GBP2022-12-31
Equity
Called up share capital
1,917 GBP2023-12-31
1,909 GBP2022-12-31
Share premium
7,029,356 GBP2023-12-31
7,029,356 GBP2022-12-31
Retained earnings (accumulated losses)
-8,135,344 GBP2023-12-31
-6,758,896 GBP2022-12-31
Equity
-1,104,071 GBP2023-12-31
272,369 GBP2022-12-31
Average Number of Employees
72023-01-01 ~ 2023-12-31
52022-01-01 ~ 2022-12-31
Property, Plant & Equipment - Gross Cost
1,426 GBP2022-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,426 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
19,167,737 shares2023-12-31

  • UTILITY THERAPEUTICS LTD
    Info
    UTILITY THERAPEUTICS GROUP LTD - 2018-02-06
    Registered number 11117843
    3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    Private Limited Company incorporated on 2017-12-19 (7 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.